title: Tolerance to cocaine's effects following chronic administration of a dose without detected effects on response rate or pause.
abstract: To observe tolerance to drug effects on operant behavior, the dose that researchers have often selected for chronic administration is one that disrupts, but does not abolish, responding. Some evidence suggests that tolerance may develop after chronic administration of relatively smaller doses. The purpose of the present experiment was to assess systematically effects of chronic administration of a dose without detected effect on responding. Specifically, response rates and post-reinforcement pauses of five pigeons key pecking under a three-component multiple fixed-ratio schedule of food reinforcement were observed under chronic cocaine administration. We evaluated the effects of a range of doses (1.0 mg/kg to 17.0  mg/kg) during acute administration. The largest dose that failed to alter responding acutely then was administered chronically (1.0  mg/kg for 1 pigeon, 3.0  mg/kg for 3 pigeons, and 5.6  mg/kg for 1 pigeon). After 30 consecutive sessions of chronic administration, smaller and larger doses occasionally were substituted for the chronic dose. Pigeons then received pre-session saline administration for 30 consecutive sessions, and the post-chronic effects of the series of doses on responding were determined. All subjects developed tolerance to doses of cocaine that initially had caused large decreases in rate, with the magnitude of the effects varying across components of the multiple schedule and subjects. Specifically, tolerance generally was greatest in the components with smaller ratios. Following post-chronic saline administration, tolerance was usually diminished. Overall, the results demonstrate that under these conditions, repeated experience with disruptive effects of cocaine on food-maintained responding is not a necessary factor in the development of tolerance.
authors.affiliation: University of Florida.
authors.forename: Vanessa
authors.initials: V
authors.lastname: Minervini
authors.forename: Marc N
authors.initials: MN
authors.lastname: Branch
mesh_terms: D000818:Animals; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D003042:Cocaine / Q000008:administration & dosage / Q000494:pharmacology*; D010856:Columbidae; D003216:Conditioning, Operant / Q000187:drug effects*; D004361:Drug Tolerance; D008297:Male; D011930:Reaction Time / Q000187:drug effects; D012054:Reinforcement, Psychology
chemical_list: D000697:Central Nervous System Stimulants; D003042:Cocaine
keywords: cocaine; fixed-ratio schedules; key peck; pigeons; tolerance
references.citation: Psychopharmacologia. 1966;9(2):170-82
references.pmid: 5983915
references.citation: J Pharmacol Exp Ther. 1955 Apr;113(4):393-401
references.pmid: 14368508
references.citation: Neuropharmacology. 1981 Oct;20(10):995-1002
references.pmid: 7301057
references.citation: J Exp Anal Behav. 1996 Jan;65(1):145-58
references.pmid: 8583194
references.citation: Behav Pharmacol. 1990;1(5):463-467
references.pmid: 11175432
references.citation: Behav Pharmacol. 2000 Nov;11(7-8):555-69
references.pmid: 11198127
references.citation: Ergeb Physiol. 1968;60:1-56
references.pmid: 4874179
references.citation: J Pharmacol Exp Ther. 1977 Apr;201(1):33-43
references.pmid: 403281
references.citation: Behav Pharmacol. 1996 Aug;7(4):324-333
references.pmid: 11224425
references.citation: NIDA Res Monogr. 1978;(18):4-17
references.pmid: 418353
references.citation: J Exp Anal Behav. 1995 Jul;64(1):61-73
references.pmid: 7622982
references.citation: Pharmacol Biochem Behav. 1982 May;16(5):713-8
references.pmid: 7089030
references.citation: Behav Pharmacol. 1993 Oct;4(5):471-478
references.pmid: 11224213
references.citation: J Exp Anal Behav. 1974 May;21(3):389-408
references.pmid: 16811752
references.citation: J Exp Anal Behav. 1986 Nov;46(3):363-79
references.pmid: 3805976
references.citation: Pharmacol Biochem Behav. 1990 Jul;36(3):473-7
references.pmid: 2377649
references.citation: Fed Proc. 1958 Dec;17(4):1024-30
references.pmid: 13619766
references.citation: J Pharmacol Exp Ther. 1966 Jun;152(3):388-96
references.pmid: 5922309
references.citation: J Exp Anal Behav. 1994 Jul;62(1):45-56
references.pmid: 8064212
references.citation: J Pharmacol Exp Ther. 1978 Jan;204(1):118-29
references.pmid: 412947
references.citation: J Exp Anal Behav. 2005 May;83(3):281-96
references.pmid: 16050038
references.citation: J Exp Anal Behav. 2010 Jul;94(1):25-36
references.pmid: 21279160
references.citation: Psychopharmacology (Berl). 1986;88(3):296-300
references.pmid: 3083449
references.citation: Psychopharmacologia. 1975 Oct 14;44(1):1-4
references.pmid: 1197574
references.citation: J Exp Anal Behav. 1991 Sep;56(2):345-60
references.pmid: 1955821
references.citation: Pharmacol Biochem Behav. 1989 Jan;32(1):267-74
references.pmid: 2734336
references.citation: J Exp Anal Behav. 1987 May;47(3):363-76
references.pmid: 3612022
references.citation: Pharmacol Biochem Behav. 2009 Oct;93(4):460-4
references.pmid: 19549535
references.citation: Behav Processes. 2004 Nov 30;67(3):363-81
references.pmid: 15518987
references.citation: J Exp Anal Behav. 1993 Mar;59(2):245-64
references.pmid: 16812686
references.citation: Psychopharmacology (Berl). 1993;113(1):67-75
references.pmid: 7862831
references.citation: Fed Proc. 1964 Jul-Aug;23:808-17
references.pmid: 14195466
references.citation: Pharmacol Biochem Behav. 1994 Jun;48(2):511-4
references.pmid: 8090823
references.citation: J Exp Anal Behav. 2004 Mar;81(2):169-88
references.pmid: 15239491
references.citation: J Pharmacol Exp Ther. 1976 Mar;196(3):605-15
references.pmid: 1263115
references.citation: Behav Pharmacol. 1994 Oct;5(6):607-614
references.pmid: 11224240
references.citation: J Pharmacol Exp Ther. 1982 Jul;222(1):126-31
references.pmid: 7086694